SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.

Loading...

Date

2021-09

Journal Title

Journal ISSN

Volume Title

Citation Stats

Attention Stats

Abstract

Background

Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling.

Methods

The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty.

Results

NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year.

Conclusion

As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.

Department

Description

Provenance

Subjects

COVIDSurg Collaborative, GlobalSurg Collaborative, Humans, Postoperative Complications, Vaccination, Prospective Studies, Comorbidity, Adolescent, Adult, Aged, Middle Aged, Female, Male, Young Adult, Preoperative Period, Elective Surgical Procedures, COVID-19, SARS-CoV-2, COVID-19 Vaccines

Citation

Published Version (Please cite this version)

10.1093/bjs/znab101

Publication Info

COVIDSurg Collaborative, GlobalSurg Collaborative (2021). SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. The British journal of surgery, 108(9). pp. 1056–1063. 10.1093/bjs/znab101 Retrieved from https://hdl.handle.net/10161/34564.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.